Executive readout · one minute
Webcast research workspace
Read the call alongside every captured source. 8-K earnings release, 10-Q stay in one workspace.
AZR
$4.00
+7.82%
AZR
· Azora Therapeutics, Inc. (DE)
$4.00
+0.29 (+7.82%)
At close · Nov 6
Return incl. dividend (before tax)
Going-concern doubt
— flagged Aug 14, 2026
Substantial doubt about the company's ability to continue as a going concern.
“the Company has concluded that there is substantial doubt about its ability to continue as a going concern.”View the 10-Q filed Aug 14, 2026
Market Cap
$10.50M
Shares
2.63M
Volume · Nov 6
78.19K
Avg daily vol (3M)
52.9K
All webcasts
Earnings call · FY2022 Q3
Azora Therapeutics, Inc. (DE) (AZR) Q3 2022 Earnings Call
Diluted EPS
-$75.50
Net income
-$3.11M
Research coverage
2 live sources
Open each available source without leaving this research workspace.
Research materials
Open the source you need; every reader stays inside this workspace.
SEC filing · Item 2.02
8-K earnings release
Filed Nov 15, 2022 · complete as-filed document
SEC periodic report
10-Q report
Filed Nov 14, 2022 · complete as-filed document